Our R&D pipeline innovations to accelerate the regeneration of tissues and organs. This contains clinical phases to transform the wound care market and chronic diseases therapies.

Our second platform of biotechnology to improve innovation including R&D of new tissue cell-based products and AEROSKIN-GUN Clinical trials.